• Wed news: Medicare $2 generics. Biogen’s high-dose Spinraza. Roche breast cancer trial. Lilly’s unique AI deal. Sage Alzheimer’s fail. See more on our front page

Moscow Mitch

anonymous

Guest
69766517_10215206876305082_8253294183461158912_n.jpg